Cargando…
New immunosuppressive drugs in heart transplantation
Only a few randomized clinical trials have been performed so far in heart transplant recipients, mainly because of the relatively small number of heart transplants performed worldwide each year. The main focus of the few controlled trials that have been completed has been the prevention and treatmen...
Autor principal: | Costanzo, Maria Rosa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59653/ https://www.ncbi.nlm.nih.gov/pubmed/11806772 http://dx.doi.org/10.1186/cvm-2-1-045 |
Ejemplares similares
-
Pharmacogenomics of Old and New Immunosuppressive Drugs for Precision Medicine in Kidney Transplantation
por: Turolo, Stefano, et al.
Publicado: (2023) -
The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
por: Yang, Fan, et al.
Publicado: (2018) -
New immunosuppressive agents in pediatric transplantation
por: Nguyen, Christina, et al.
Publicado: (2014) -
Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center
por: Chang, David H., et al.
Publicado: (2020) -
Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression
por: Zuckermann, Andreas, et al.
Publicado: (2015)